Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHair shedding during Mounjaro treatment is real, more common than the patient leaflet might suggest, and in most cases temporary. The medical term is telogen effluvium — a stress response where rapid weight loss prompts hair follicles to shift into a resting phase simultaneously, causing noticeable shedding weeks later. It is not a direct toxicity of tirzepatide itself, and understanding that distinction is the first step in preventing or minimising hair loss on Mounjaro. These are prescription-only medicines; a GPhC-registered prescriber assesses your full picture before treatment starts, and that conversation is the right place to raise any concerns about this.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most hair loss reported during Mounjaro treatment follows a clear pattern: it begins roughly two to four months after treatment starts, peaks over a few weeks, then gradually slows. This lag is the hallmark of telogen effluvium. Follicles that entered the resting phase when the body registered a significant calorie deficit begin to shed together once that resting cycle completes. Tirzepatide's appetite-suppressing effect is doing its job, but if food intake drops sharply without careful nutritional planning, the follicles pay the price.
This matters for prevention, because the intervention isn't about changing how the medicine works. It's about what you eat and how quickly you lose weight. The wider picture of Mounjaro and hair loss covers the mechanism in more detail, but the practical takeaway is this: slow, supported weight loss with good protein intake causes less follicular stress than rapid loss on a very restrictive diet. That's the lever you can pull.
One thing worth knowing: shedding is most noticeable when washing or brushing, and it can look alarming. Seeing fifty to a hundred hairs on a brush is within the normal daily range for someone not on any treatment at all. The question is whether what you're seeing is meaningfully above your baseline, and that's a conversation worth having with your prescriber.
Hair follicles are among the most metabolically active structures in the body. When calories fall, the body prioritises organs over follicles. Prevention, then, starts at the plate. Hitting a minimum of 1.2 to 1.6 grams of protein per kilogram of body weight each day is widely recommended for people losing weight actively; some clinical dietitians suggest the upper end of that range during GLP-1 treatment because appetite suppression can quietly reduce total intake. Lean meats, eggs, legumes, Greek yoghurt, and fish all count.
Iron, zinc, biotin, and vitamin D are also implicated in hair follicle health. A full blood panel at the start of treatment (and again if shedding becomes noticeable) can identify deficiencies that a targeted supplement might address. Blanket supplementation without knowing your levels is less useful; a blood test costs little and gives a clear answer. Your GP can arrange one, or raise it with a prescriber during your clinical review.
Hydration matters too. Mounjaro slows gastric emptying, and some people quietly reduce their fluid intake alongside their food intake. Keeping water intake up supports circulation to the scalp and the general metabolic environment follicles need. The practical steps for preventing hair loss while on Mounjaro include a closer look at daily nutrition targets and how to hit them when appetite is reduced.
The rate of weight loss matters as much as the total. Very rapid loss (more than about one kilogram per week sustained over months) is consistently linked to more pronounced telogen effluvium. Tirzepatide's dose titration schedule is partly designed to allow the body to adapt gradually, and staying at a given dose until it's tolerated well, rather than pushing for the highest dose as fast as possible, is clinically sensible for more than one reason.
If you notice shedding starting, log when it began and tell your prescriber. In some cases, holding a dose rather than increasing it gives the body time to adjust. Prescribers at nume review your progress before every repeat order (not just at the start) so there are regular checkpoints built in. No dose increase happens without clinical re-review. Alongside that, the broader side-effect profile of Mounjaro is something our prescribers discuss as part of assessing whether a dose change is appropriate.
Stress compounds telogen effluvium. Poor sleep, intense exercise without adequate fuelling, and psychological stress all push follicles toward the resting phase. None of this means you should avoid exercise (quite the opposite) but pairing activity with enough food to support it matters more during active weight loss than at any other time. A holiday, a run of sleepless weeks at work, or an unusually demanding month can all coincide with a patch of heavier shedding; noticing those overlaps helps put the shedding in context rather than attributing everything to the medicine.
Telogen effluvium is diffuse and gradual. Hair loss that follows a different pattern needs medical assessment promptly. Seek advice from your GP or a dermatologist if you notice patchy bald spots, sudden very heavy loss over a short period, scalp redness, scaling or pain, or if the shedding does not slow after six months. These presentations can indicate alopecia areata, a fungal infection, or an autoimmune condition that is unrelated to your treatment and needs its own investigation.
Significant hair thinning alongside fatigue, feeling cold all the time, or unexplained weight changes beyond what Mounjaro accounts for can point to a thyroid problem. Thyroid dysfunction is both a risk factor for hair loss and a condition sometimes uncovered incidentally during weight-loss treatment when people pay closer attention to how they feel. A simple blood test rules it in or out.
The NHS provides useful patient-level information about tirzepatide and its side effects at the NHS Medicines page for tirzepatide, including what to report to a doctor. If you experience any symptom you're uncertain about, the MHRA asks patients to report it via the Yellow Card scheme, this is especially valuable for newer medicines like tirzepatide, which carries a Black Triangle (▼) status indicating it is subject to additional monitoring. You can also contact our prescribers directly through the nume support team, seven days a week.
For people concerned about other gastrointestinal effects alongside treatment, guidance on managing things like diarrhoea during Mounjaro treatment or sulphur burps follows similar principles: early awareness, dietary adjustment, and prescriber involvement if symptoms are persistent.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.